The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ORIC Pharmaceuticals, Inc(NASDAQ:ORIC) 
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. The company's lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of ...
Website: http://www.oricpharma.com
Full Time Employees: 60
CEO: Jacob M. Chacko
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
ORIC Pharmaceuticals Days Payable Outstanding ttm (DPO)
ORIC Pharmaceuticals Op Cashflow Per Share ttm
ORIC Pharmaceuticals Free Cashflow Per Share ttm
ORIC Pharmaceuticals Cash Per Share ttm
ORIC Pharmaceuticals (GAAP) P/E ratio ttm
ORIC Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.